NGVT
Ingevity Corporation · Basic Materials · Chemicals - Specialty
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | +2 | 24.32M | $1.82B | +9 | −6 |
| Q1 2026 | 103 | +2 | 24.86M | $1.77B | +8 | −6 |
| Q4 2025 | 101 | 0 | 27.65M | $1.64B | — | — |
| Q3 2025 | 21 | +2 | 17.28M | $953.51M | +2 | — |
| Q2 2025 | 16 | +1 | 16.56M | $713.77M | +1 | — |
| Q1 2025 | 12 | +1 | 6.33M | $250.43M | +1 | — |
| Q4 2024 | 11 | 0 | 6.19M | $252.36M | — | — |
| Q3 2024 | 10 | -3 | 4.46M | $174.12M | — | −3 |
| Q2 2024 | 13 | — | 4.12M | $179.92M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 2.18M | — | $95.26M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 2.18M | — | $95.26M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 2.18M | — | $95.26M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 2.18M | — | $95.26M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 2.18M | — | $95.26M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.18M | — | $95.26M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 781.69K | — | $34.17M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passive) | 781.69K | — | $34.17M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Millennium Management ✦ | 504.55K | — | $22.05M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Marshall Wace ✦ | 219.15K | — | $9.58M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Norges Bank ✦ (passive) | 93.70K | — | $4.10M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 93.59K | — | $4.09M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 93.23K | — | $4.08M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 93.23K | — | $4.08M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | PRIMECAP Management ✦ | 69.00K | — | $3.02M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 32.36K | — | $1.42M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 32.36K | — | $1.42M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 19.04K | — | $832,020 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 12.46K | — | $544,452 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Arrowstreet Capital ✦ | 9.54K | — | $417,000 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 8.39K | — | $366,815 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 8.39K | — | $366,815 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 8.39K | — | $366,815 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 303 holders, 35.66M shares, $2.45B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer, Director · 92 sh · $6,873
Officer, Director · 5.00K sh · $379,150
Officer, Director · 5.00K sh · $378,650
Officer, Director · 5.00K sh · $378,650
Officer, Director · 5.00K sh · $383,100
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology